Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Ivor Douglas

Concepts (598)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Respiration, Artificial
24
2025
604
3.870
 Why?
Sepsis
20
2025
569
2.890
 Why?
Fluid Therapy
12
2025
134
2.510
 Why?
Respiratory Insufficiency
12
2023
311
2.360
 Why?
Critical Care
19
2025
551
2.290
 Why?
Critical Illness
20
2025
755
2.130
 Why?
Intensive Care Units
24
2025
735
2.100
 Why?
Tracheostomy
5
2024
120
1.780
 Why?
Shock, Septic
11
2024
208
1.600
 Why?
Hospital Mortality
19
2024
847
1.540
 Why?
Shock
3
2024
92
1.470
 Why?
Hospitals
6
2023
637
1.300
 Why?
Hypotension
5
2025
115
1.260
 Why?
Pneumonia
7
2023
601
1.170
 Why?
Resuscitation Orders
3
2023
46
1.030
 Why?
Resuscitation
9
2025
234
0.990
 Why?
Multiple Organ Failure
4
2024
122
0.980
 Why?
Humans
135
2025
128499
0.880
 Why?
Patient Readmission
6
2021
665
0.880
 Why?
Vasoconstrictor Agents
5
2023
127
0.870
 Why?
Ultrasonography, Doppler
1
2024
118
0.850
 Why?
Middle Aged
58
2025
30923
0.830
 Why?
Pneumonia, Ventilator-Associated
2
2015
47
0.820
 Why?
Aged
45
2025
21976
0.820
 Why?
Safety-net Providers
3
2023
109
0.760
 Why?
Hospitals, High-Volume
2
2019
39
0.750
 Why?
Hemodynamics
3
2024
1077
0.740
 Why?
Severity of Illness Index
6
2021
2719
0.720
 Why?
Monitoring, Physiologic
4
2024
264
0.720
 Why?
Extracorporeal Membrane Oxygenation
2
2023
281
0.720
 Why?
Retrospective Studies
31
2025
14472
0.710
 Why?
Patient Acceptance of Health Care
5
2021
757
0.700
 Why?
Patient Positioning
1
2021
52
0.700
 Why?
Male
73
2025
63045
0.700
 Why?
Frailty
1
2023
153
0.690
 Why?
Diabetes Insipidus
1
2020
7
0.680
 Why?
Practice Guidelines as Topic
6
2021
1490
0.660
 Why?
Substance Withdrawal Syndrome
3
2021
172
0.640
 Why?
Hospitals, Low-Volume
1
2019
22
0.630
 Why?
Noninvasive Ventilation
4
2025
49
0.610
 Why?
Dyspnea
2
2021
239
0.600
 Why?
Female
64
2025
68268
0.580
 Why?
Adult
44
2025
35302
0.570
 Why?
Delirium
3
2025
78
0.570
 Why?
Pulmonary Disease, Chronic Obstructive
8
2025
953
0.560
 Why?
Diabetes Mellitus
2
2020
996
0.550
 Why?
Alcoholism
5
2021
765
0.540
 Why?
Ventilator-Induced Lung Injury
3
2018
56
0.530
 Why?
Pulmonary Medicine
3
2015
78
0.520
 Why?
California
5
2022
398
0.520
 Why?
Microbiological Techniques
1
2016
30
0.510
 Why?
Sleep Medicine Specialty
1
2015
9
0.500
 Why?
Acute Lung Injury
6
2023
264
0.500
 Why?
Neoplasms
3
2023
2463
0.490
 Why?
Molecular Diagnostic Techniques
1
2016
98
0.480
 Why?
Health Policy
4
2024
351
0.480
 Why?
Hyperemia
3
2024
46
0.470
 Why?
Ethanol
2
2021
585
0.470
 Why?
Randomized Controlled Trials as Topic
10
2023
1358
0.470
 Why?
Acute Kidney Injury
7
2023
779
0.450
 Why?
Research Design
9
2023
1036
0.450
 Why?
Aged, 80 and over
13
2025
7057
0.440
 Why?
Cohort Studies
11
2023
5402
0.430
 Why?
Renin-Angiotensin System
2
2025
79
0.430
 Why?
Prone Position
3
2021
30
0.420
 Why?
Receptor, EphA2
3
2018
20
0.420
 Why?
Bronchoalveolar Lavage Fluid
2
2016
624
0.420
 Why?
Cause of Death
3
2015
392
0.410
 Why?
Inpatients
3
2023
468
0.410
 Why?
Laryngoscopes
2
2023
34
0.410
 Why?
Immune Tolerance
1
2015
350
0.400
 Why?
Nicotinic Agonists
1
2014
125
0.400
 Why?
Dual Specificity Phosphatase 1
1
2012
26
0.400
 Why?
Cross Infection
5
2020
216
0.390
 Why?
Marijuana Smoking
1
2015
239
0.390
 Why?
Hospitalization
10
2025
2069
0.380
 Why?
Apoptosis
6
2014
2437
0.380
 Why?
Lung
12
2018
3748
0.380
 Why?
Tobacco Use Disorder
1
2014
237
0.370
 Why?
Nicotine
1
2014
302
0.370
 Why?
Lipopolysaccharides
4
2017
859
0.360
 Why?
Organ Dysfunction Scores
2
2024
44
0.360
 Why?
Pulmonary Fibrosis
4
2017
377
0.360
 Why?
Tissue Plasminogen Activator
2
2024
222
0.360
 Why?
Immunity, Innate
1
2017
803
0.360
 Why?
Drug Delivery Systems
1
2014
327
0.350
 Why?
Protein C
5
2012
47
0.350
 Why?
Glycosaminoglycans
3
2016
84
0.350
 Why?
Prospective Studies
12
2024
7069
0.350
 Why?
Child Development
1
2015
455
0.340
 Why?
Long-Term Care
2
2022
91
0.340
 Why?
Emergency Service, Hospital
5
2024
1900
0.330
 Why?
Smoking Cessation
1
2014
407
0.330
 Why?
Antipsychotic Agents
2
2024
192
0.320
 Why?
Vena Cava, Inferior
3
2024
68
0.320
 Why?
Comorbidity
4
2022
1541
0.320
 Why?
Metabolic Syndrome
2
2023
338
0.320
 Why?
Ephrin-A1
3
2018
4
0.310
 Why?
Public Health
1
2014
482
0.310
 Why?
Treatment Outcome
15
2024
10162
0.310
 Why?
Length of Stay
6
2024
1119
0.310
 Why?
United States
18
2024
13840
0.310
 Why?
Cannabis
1
2015
426
0.310
 Why?
Lipid A
2
2014
29
0.300
 Why?
Institutional Practice
1
2008
3
0.300
 Why?
Intubation, Intratracheal
4
2024
238
0.300
 Why?
Societies, Medical
7
2021
744
0.300
 Why?
Biomarkers
7
2023
3893
0.290
 Why?
Betacoronavirus
2
2020
247
0.290
 Why?
Odds Ratio
6
2019
1019
0.290
 Why?
Personnel Staffing and Scheduling
1
2008
88
0.290
 Why?
Pandemics
4
2024
1477
0.280
 Why?
Neutrophils
3
2024
1192
0.280
 Why?
Pulmonary Alveolar Proteinosis
1
2007
17
0.270
 Why?
Integrins
1
2007
92
0.270
 Why?
Anti-Bacterial Agents
1
2017
1705
0.270
 Why?
Neovascularization, Pathologic
2
2007
290
0.270
 Why?
Haloperidol
3
2025
32
0.270
 Why?
MAP Kinase Signaling System
2
2014
307
0.260
 Why?
Patient Admission
2
2023
182
0.260
 Why?
Hyponatremia
1
2006
40
0.260
 Why?
Lung Injury
3
2016
199
0.260
 Why?
Lung Diseases, Obstructive
1
2006
44
0.260
 Why?
Renal Insufficiency, Chronic
2
2024
564
0.260
 Why?
Ultrasonography
3
2024
712
0.250
 Why?
Leukocytes
1
2007
303
0.250
 Why?
Double-Blind Method
9
2024
1856
0.250
 Why?
Pneumonia, Viral
2
2020
337
0.250
 Why?
Coronavirus Infections
2
2020
333
0.250
 Why?
Medicaid
3
2021
433
0.240
 Why?
Laryngoscopy
2
2023
99
0.240
 Why?
Biomedical Research
3
2021
633
0.240
 Why?
Chemokines, CXC
1
2005
68
0.240
 Why?
Bronchi
1
2006
241
0.240
 Why?
Academic Medical Centers
3
2021
480
0.240
 Why?
Regeneration
1
2006
176
0.240
 Why?
Oxazines
1
2024
27
0.230
 Why?
Bronchiectasis
1
2006
108
0.230
 Why?
Bronchiolitis Obliterans
1
2005
64
0.230
 Why?
Adrenal Insufficiency
2
2013
32
0.230
 Why?
Infusions, Intravenous
5
2024
394
0.230
 Why?
Methylprednisolone
1
2005
82
0.230
 Why?
Phagocytosis
1
2006
361
0.230
 Why?
Venous Pressure
1
2024
8
0.230
 Why?
Patient Protection and Affordable Care Act
2
2016
100
0.220
 Why?
Plasminogen
1
2024
31
0.220
 Why?
Morpholines
1
2024
122
0.220
 Why?
Leukocyte Elastase
1
2024
74
0.220
 Why?
Respiratory Mucosa
1
2006
304
0.220
 Why?
Vasopressins
3
2021
64
0.220
 Why?
Plasminogen Activator Inhibitor 1
1
2024
84
0.220
 Why?
Anti-Infective Agents
4
2012
245
0.220
 Why?
beta Catenin
1
2005
218
0.220
 Why?
Cytokines
7
2017
1994
0.220
 Why?
Hypoxia
3
2024
1035
0.210
 Why?
Atrial Pressure
1
2023
3
0.210
 Why?
Renal Dialysis
4
2023
423
0.210
 Why?
Receptor, Angiotensin, Type 1
1
2023
21
0.210
 Why?
Diterpenes
2
2014
32
0.210
 Why?
Risk Factors
10
2021
9737
0.210
 Why?
Area Under Curve
3
2020
293
0.210
 Why?
Analgesics, Non-Narcotic
1
2024
118
0.210
 Why?
Craniocerebral Trauma
1
2005
151
0.210
 Why?
Lung Diseases
3
2016
715
0.210
 Why?
Hemodynamic Monitoring
1
2022
1
0.200
 Why?
Fibrinolysis
1
2024
137
0.200
 Why?
Thiazoles
2
2024
115
0.200
 Why?
Fibrosis
1
2005
513
0.200
 Why?
Treatment Failure
6
2021
338
0.200
 Why?
Evidence-Based Medicine
5
2016
712
0.190
 Why?
Acetaminophen
1
2024
245
0.190
 Why?
Early Diagnosis
4
2017
234
0.190
 Why?
Transportation
1
2022
50
0.190
 Why?
Clinical Decision-Making
1
2024
302
0.190
 Why?
Hydrocortisone
1
2003
304
0.180
 Why?
Logistic Models
7
2017
1980
0.180
 Why?
Vasodilator Agents
1
2023
324
0.180
 Why?
Pyridines
1
2024
474
0.180
 Why?
Heart Arrest
2
2021
307
0.180
 Why?
Central Nervous System Depressants
1
2021
82
0.180
 Why?
Receptors, Interleukin-6
1
2021
37
0.180
 Why?
Stroke Volume
1
2024
589
0.180
 Why?
Hospital Charges
1
2020
41
0.180
 Why?
Piperazines
2
2024
333
0.170
 Why?
Health Priorities
1
2020
34
0.170
 Why?
Rib Fractures
1
2020
32
0.170
 Why?
Hydroxychloroquine
1
2020
55
0.170
 Why?
Glucocorticoids
1
2005
573
0.170
 Why?
Community-Acquired Infections
3
2020
160
0.170
 Why?
Internship and Residency
2
2019
1045
0.170
 Why?
Reproducibility of Results
5
2024
3021
0.170
 Why?
Antigens, Differentiation
1
2000
82
0.170
 Why?
Animals
20
2018
34647
0.170
 Why?
Heart Failure
3
2023
2145
0.160
 Why?
Cell Proliferation
2
2014
2345
0.160
 Why?
Patient Selection
1
2023
661
0.160
 Why?
Patient Handoff
1
2019
31
0.160
 Why?
Risk Adjustment
1
2020
79
0.160
 Why?
Mice, Inbred C57BL
9
2018
5281
0.160
 Why?
Cell Adhesion Molecules
1
2000
173
0.150
 Why?
Hospital Costs
1
2019
114
0.150
 Why?
Dopamine Antagonists
1
2018
23
0.150
 Why?
Age Factors
4
2019
3122
0.150
 Why?
Combined Modality Therapy
2
2020
1201
0.150
 Why?
ROC Curve
1
2020
502
0.150
 Why?
Blood Glucose Self-Monitoring
1
2023
601
0.150
 Why?
Antimicrobial Stewardship
1
2020
102
0.150
 Why?
Orthopedic Procedures
1
2020
207
0.150
 Why?
Thrombosis
1
2021
343
0.140
 Why?
Caregivers
1
2025
813
0.140
 Why?
Optometry
1
2017
6
0.140
 Why?
Health Services Accessibility
4
2020
901
0.140
 Why?
Platelet Count
2
2014
82
0.140
 Why?
Eosinophils
1
2000
323
0.140
 Why?
Guideline Adherence
2
2014
524
0.140
 Why?
Cell Adhesion
4
2012
445
0.140
 Why?
Tidal Volume
2
2014
82
0.140
 Why?
Predictive Value of Tests
4
2016
1938
0.140
 Why?
Blood Glucose
2
2023
2092
0.140
 Why?
Lymphocyte Count
1
2017
150
0.130
 Why?
Analysis of Variance
1
2020
1273
0.130
 Why?
Transients and Migrants
1
2017
25
0.130
 Why?
Pyrimidines
2
2024
449
0.130
 Why?
Mice
13
2017
16620
0.130
 Why?
Tretinoin
1
2017
127
0.130
 Why?
Cystic Fibrosis
1
2006
1049
0.130
 Why?
Nephrectomy
2
2008
158
0.130
 Why?
Health Insurance Exchanges
1
2016
1
0.130
 Why?
Delivery of Health Care
1
2023
889
0.130
 Why?
Risk Management
1
2017
85
0.130
 Why?
Continuity of Patient Care
1
2018
275
0.130
 Why?
Attitude of Health Personnel
3
2019
1090
0.130
 Why?
Clinical Trials as Topic
1
2021
1003
0.130
 Why?
Ventricular Function, Right
1
2018
275
0.130
 Why?
Sleep Wake Disorders
2
2017
250
0.130
 Why?
Breath Tests
1
2016
89
0.130
 Why?
Antibodies, Monoclonal, Humanized
1
2021
758
0.120
 Why?
Ventricular Dysfunction, Right
1
2018
228
0.120
 Why?
Burnout, Professional
1
2021
407
0.120
 Why?
Respiratory Tract Diseases
1
2017
148
0.120
 Why?
Research
1
2018
409
0.120
 Why?
Survival Analysis
4
2014
1265
0.120
 Why?
Alcohol Withdrawal Seizures
1
2014
1
0.120
 Why?
Alcohol Withdrawal Delirium
1
2014
7
0.120
 Why?
Marriage
1
2016
113
0.120
 Why?
Staphylococcus aureus
2
2011
436
0.120
 Why?
Bronchoalveolar Lavage
1
2015
89
0.120
 Why?
Automation
1
2015
80
0.120
 Why?
5-Lipoxygenase-Activating Protein Inhibitors
1
2014
1
0.120
 Why?
5-Lipoxygenase-Activating Proteins
1
2014
2
0.120
 Why?
Bacteriological Techniques
1
2015
68
0.120
 Why?
Prognosis
5
2021
3780
0.120
 Why?
Risk Assessment
5
2015
3232
0.110
 Why?
Multicenter Studies as Topic
3
2023
286
0.110
 Why?
Patient Care Team
1
2019
598
0.110
 Why?
Leukotrienes
1
2014
34
0.110
 Why?
Fluorobenzenes
1
2014
15
0.110
 Why?
Phenanthrenes
1
2014
12
0.110
 Why?
Physicians
2
2021
863
0.110
 Why?
APACHE
2
2011
65
0.110
 Why?
Quality of Life
2
2024
2688
0.110
 Why?
Education, Medical
1
2017
244
0.110
 Why?
Potassium
1
2014
139
0.110
 Why?
Down-Regulation
2
2017
632
0.110
 Why?
Catheterization, Central Venous
1
2015
103
0.110
 Why?
Alanine Transaminase
1
2014
151
0.110
 Why?
Poverty
2
2016
497
0.110
 Why?
Systemic Inflammatory Response Syndrome
1
2014
85
0.110
 Why?
CD4-Positive T-Lymphocytes
1
2000
1045
0.110
 Why?
Kaplan-Meier Estimate
5
2018
856
0.110
 Why?
Laryngeal Masks
1
2013
10
0.110
 Why?
Microscopy
1
2015
140
0.110
 Why?
Quinolines
1
2014
155
0.100
 Why?
Time Factors
7
2023
6506
0.100
 Why?
Glycocalyx
1
2012
19
0.100
 Why?
Health Knowledge, Attitudes, Practice
2
2024
1276
0.100
 Why?
Sensitivity and Specificity
2
2015
1817
0.100
 Why?
Patient-Centered Care
1
2017
497
0.100
 Why?
Patient Discharge
1
2018
854
0.100
 Why?
Physician-Patient Relations
1
2017
530
0.100
 Why?
Supine Position
1
2012
38
0.100
 Why?
Acute Disease
3
2016
965
0.100
 Why?
Cisplatin
1
2014
298
0.100
 Why?
Biomarkers, Pharmacological
1
2012
26
0.100
 Why?
Oxygen
3
2023
901
0.100
 Why?
Data Interpretation, Statistical
2
2011
335
0.100
 Why?
I-kappa B Proteins
1
2012
73
0.100
 Why?
Clinical Alarms
1
2011
10
0.090
 Why?
Insurance, Health
1
2014
267
0.090
 Why?
Data Display
1
2011
20
0.090
 Why?
Health Status
1
2017
747
0.090
 Why?
Follow-Up Studies
5
2024
4874
0.090
 Why?
Endotoxemia
1
2012
83
0.090
 Why?
Adrenergic beta-2 Receptor Agonists
1
2011
35
0.090
 Why?
Indoles
1
2014
372
0.090
 Why?
Albuterol
1
2011
103
0.090
 Why?
Genetic Markers
1
2012
338
0.090
 Why?
Sulfonamides
1
2014
495
0.090
 Why?
Fibrinolytic Agents
2
2024
261
0.090
 Why?
Alcohol-Related Disorders
1
2011
118
0.080
 Why?
Peroxidase
2
2008
169
0.080
 Why?
Stenotrophomonas maltophilia
1
2009
2
0.080
 Why?
Recombinant Proteins
5
2012
1291
0.080
 Why?
Decision Making
1
2017
847
0.080
 Why?
Thoracic Diseases
1
2009
14
0.080
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
411
0.080
 Why?
Clinical Protocols
2
2012
254
0.080
 Why?
Interferons
1
2011
192
0.080
 Why?
Survival Rate
3
2015
1871
0.080
 Why?
Wounds and Injuries
1
2016
707
0.080
 Why?
Adrenal Cortex Hormones
1
2013
518
0.080
 Why?
Ligands
2
2023
617
0.080
 Why?
Symptom Assessment
2
2020
124
0.080
 Why?
Gram-Negative Bacterial Infections
1
2009
44
0.080
 Why?
Blotting, Western
1
2012
1170
0.080
 Why?
Cell Movement
3
2011
936
0.080
 Why?
Disease Models, Animal
5
2018
3947
0.080
 Why?
Databases, Factual
2
2016
1267
0.080
 Why?
Polymerase Chain Reaction
1
2012
1027
0.080
 Why?
Up-Regulation
1
2012
823
0.080
 Why?
Confidence Intervals
1
2010
316
0.080
 Why?
Cues
1
2011
325
0.080
 Why?
Age Distribution
1
2010
373
0.080
 Why?
Sex Distribution
1
2010
358
0.080
 Why?
Pancreatitis
1
2009
128
0.080
 Why?
Pneumonia, Bacterial
1
2009
112
0.080
 Why?
Pulmonary Alveoli
2
2012
365
0.080
 Why?
Work Schedule Tolerance
1
2008
42
0.070
 Why?
Models, Statistical
1
2012
622
0.070
 Why?
Clinical Trials, Phase III as Topic
2
2023
92
0.070
 Why?
Healthcare Disparities
1
2014
579
0.070
 Why?
Incidence
1
2014
2638
0.070
 Why?
United Kingdom
1
2008
258
0.070
 Why?
Pulmonary Emphysema
2
2007
245
0.070
 Why?
Interleukin-6
2
2008
715
0.070
 Why?
Mandatory Programs
1
2007
14
0.070
 Why?
Flavonoids
1
2007
78
0.070
 Why?
Child, Preschool
2
2015
10487
0.070
 Why?
Clinical Competence
1
2014
1009
0.070
 Why?
Demeclocycline
1
2006
3
0.070
 Why?
Rats, Sprague-Dawley
1
2012
2272
0.070
 Why?
Disease Progression
4
2017
2604
0.070
 Why?
Mice, Inbred C3H
1
2007
273
0.070
 Why?
Lithium Compounds
1
2006
11
0.070
 Why?
Methicillin Resistance
1
2006
17
0.070
 Why?
Signal Transduction
4
2018
4825
0.070
 Why?
Workload
1
2008
151
0.070
 Why?
Mitogen-Activated Protein Kinase 3
1
2007
147
0.070
 Why?
Carcinoma, Non-Small-Cell Lung
1
1995
1046
0.070
 Why?
Mitogen-Activated Protein Kinase 1
1
2007
180
0.060
 Why?
Intercellular Adhesion Molecule-1
2
2012
133
0.060
 Why?
Diuretics
1
2006
75
0.060
 Why?
Receptors, Antigen, T-Cell, gamma-delta
1
2006
100
0.060
 Why?
Hospitals, Urban
2
2018
129
0.060
 Why?
Hospital Information Systems
1
2006
14
0.060
 Why?
Mesoderm
1
2007
136
0.060
 Why?
Sex Factors
3
2018
1951
0.060
 Why?
History, 20th Century
2
2017
288
0.060
 Why?
Rats
2
2012
5246
0.060
 Why?
Adolescent
5
2025
20304
0.060
 Why?
Asparagine
1
2005
29
0.060
 Why?
Radiography, Thoracic
1
2007
164
0.060
 Why?
Butylated Hydroxytoluene
1
2005
38
0.060
 Why?
Mice, Inbred BALB C
2
2005
1227
0.060
 Why?
Emphysema
1
2006
94
0.060
 Why?
Hypertension, Pulmonary
2
2007
1749
0.060
 Why?
Protein Kinase Inhibitors
2
2024
880
0.060
 Why?
Cyclin D1
1
2005
63
0.060
 Why?
Vocabulary
1
2006
46
0.060
 Why?
Bronchoscopy
1
2007
208
0.060
 Why?
Heparin
1
2007
253
0.060
 Why?
Cell Line, Transformed
1
2005
141
0.060
 Why?
Young Adult
5
2025
12349
0.060
 Why?
Medical Order Entry Systems
1
2006
43
0.060
 Why?
Caspase Inhibitors
1
2005
77
0.060
 Why?
Occupational Health
1
2008
192
0.060
 Why?
Blood Vessels
1
2007
183
0.060
 Why?
Gene Expression Regulation
2
2012
2516
0.060
 Why?
Angiotensin I
1
2025
7
0.060
 Why?
Venous Thrombosis
1
2007
176
0.060
 Why?
Gene Expression Profiling
1
2012
1689
0.060
 Why?
Ischemia
1
2008
394
0.060
 Why?
Androstanols
1
2024
9
0.060
 Why?
Neuromuscular Nondepolarizing Agents
1
2024
13
0.060
 Why?
Necrosis
1
2005
229
0.060
 Why?
HMGB1 Protein
1
2005
48
0.060
 Why?
Caspases
1
2005
240
0.060
 Why?
Pyridazines
1
2024
51
0.060
 Why?
Hope
1
2024
22
0.060
 Why?
Macrophages
2
2014
1464
0.060
 Why?
Colorado
4
2017
4399
0.060
 Why?
Medicago
1
2023
1
0.060
 Why?
Cadherins
1
2005
188
0.060
 Why?
T-Lymphocyte Subsets
1
2006
409
0.060
 Why?
Diabetic Ketoacidosis
1
2007
197
0.060
 Why?
Renal Replacement Therapy
1
2024
87
0.060
 Why?
Steroids
2
2021
147
0.060
 Why?
Uncertainty
1
2024
114
0.050
 Why?
Practice Patterns, Physicians'
3
2024
1262
0.050
 Why?
Enzyme Inhibitors
1
2007
813
0.050
 Why?
Atrial Function, Right
1
2023
12
0.050
 Why?
Angiotensins
1
2023
9
0.050
 Why?
Multivariate Analysis
2
2017
1499
0.050
 Why?
Collagen
1
2005
430
0.050
 Why?
Heparitin Sulfate
2
2014
41
0.050
 Why?
Mental Health
2
2022
683
0.050
 Why?
Drug Administration Schedule
2
2018
764
0.050
 Why?
Biopsy
1
2007
1079
0.050
 Why?
Inflammatory Bowel Diseases
1
2007
320
0.050
 Why?
Antineoplastic Agents
1
2014
2042
0.050
 Why?
Autoimmune Diseases
1
2006
424
0.050
 Why?
Homeostasis
1
2006
606
0.050
 Why?
Angiotensin II
1
2023
93
0.050
 Why?
Decision Support Techniques
2
2020
396
0.050
 Why?
Anticoagulants
1
2007
634
0.050
 Why?
Diagnosis, Differential
1
2007
1412
0.050
 Why?
Video Recording
1
2023
161
0.050
 Why?
Lung Neoplasms
1
1995
2329
0.050
 Why?
Hemoglobins
1
2024
337
0.050
 Why?
Child
2
2015
20805
0.050
 Why?
p38 Mitogen-Activated Protein Kinases
2
2014
268
0.050
 Why?
Endothelial Cells
1
2007
703
0.050
 Why?
Staphylococcal Infections
1
2006
392
0.050
 Why?
Partial Thromboplastin Time
1
2021
52
0.050
 Why?
Creatinine
2
2015
480
0.050
 Why?
Infant
1
2015
9001
0.050
 Why?
Oligopeptides
1
2023
255
0.050
 Why?
Perioperative Care
1
2022
150
0.040
 Why?
Electrocardiography
1
2024
608
0.040
 Why?
Antibodies
2
2018
394
0.040
 Why?
Peptide Fragments
1
2025
688
0.040
 Why?
Lung Diseases, Interstitial
1
2007
592
0.040
 Why?
Leukotriene C4
1
2000
11
0.040
 Why?
Hemorrhage
1
2005
666
0.040
 Why?
CD18 Antigens
1
2000
26
0.040
 Why?
N-Formylmethionine Leucyl-Phenylalanine
1
2000
54
0.040
 Why?
Chronic Disease
1
2006
1692
0.040
 Why?
Drug Resistance, Microbial
1
2020
68
0.040
 Why?
CD11 Antigens
1
2000
29
0.040
 Why?
Glasgow Coma Scale
1
2020
167
0.040
 Why?
Costs and Cost Analysis
1
2020
200
0.040
 Why?
Epithelial Cells
1
2005
1043
0.040
 Why?
Smoking
1
2006
1459
0.040
 Why?
Hospitals, University
1
2019
176
0.040
 Why?
Flow Cytometry
2
2017
1142
0.040
 Why?
Needs Assessment
1
2021
356
0.040
 Why?
Oxidative Stress
1
2005
1191
0.040
 Why?
Aftercare
1
2001
206
0.040
 Why?
NF-kappa B
2
2018
650
0.040
 Why?
Surveys and Questionnaires
3
2021
5371
0.040
 Why?
Infection Control
1
2020
138
0.040
 Why?
Algorithms
1
2006
1614
0.040
 Why?
Adjuvants, Immunologic
1
2000
221
0.040
 Why?
Injury Severity Score
1
2020
509
0.040
 Why?
Class Ib Phosphatidylinositol 3-Kinase
1
2018
4
0.040
 Why?
Mice, Knockout
3
2012
2765
0.040
 Why?
Linear Models
1
2020
816
0.040
 Why?
T-Lymphocytes
1
2006
1923
0.040
 Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2018
34
0.040
 Why?
Trauma Centers
1
2020
401
0.040
 Why?
Victoria
1
2017
16
0.040
 Why?
Mortality
1
2019
306
0.030
 Why?
Family
1
2022
649
0.030
 Why?
History, 17th Century
1
2017
14
0.030
 Why?
Antigens, CD
1
2000
482
0.030
 Why?
History, 16th Century
1
2017
14
0.030
 Why?
History, 15th Century
1
2017
11
0.030
 Why?
United Arab Emirates
1
2017
7
0.030
 Why?
History, Ancient
1
2017
52
0.030
 Why?
History, Medieval
1
2017
44
0.030
 Why?
Recovery of Function
1
2021
633
0.030
 Why?
Drug Therapy, Combination
2
2012
1016
0.030
 Why?
Critical Care Outcomes
1
2016
12
0.030
 Why?
Stress Disorders, Post-Traumatic
1
2025
821
0.030
 Why?
History, 21st Century
1
2017
180
0.030
 Why?
Cross-Sectional Studies
2
2021
5045
0.030
 Why?
Trauma Severity Indices
1
2016
104
0.030
 Why?
Probability
1
2017
306
0.030
 Why?
Lymphocyte Activation
1
2000
1098
0.030
 Why?
Proto-Oncogene Proteins c-akt
1
2018
420
0.030
 Why?
Refugees
1
2017
65
0.030
 Why?
Uteroglobin
1
2014
21
0.030
 Why?
Anxiety
1
2022
952
0.030
 Why?
Chemokine CXCL2
1
2014
43
0.030
 Why?
Cost-Benefit Analysis
1
2017
569
0.030
 Why?
Pilot Projects
1
2019
1568
0.030
 Why?
Arachidonate 5-Lipoxygenase
1
2014
38
0.030
 Why?
Rosuvastatin Calcium
1
2014
20
0.030
 Why?
Nitrites
1
2014
81
0.030
 Why?
MAP Kinase Kinase 4
1
2014
28
0.030
 Why?
Risk
1
2017
853
0.030
 Why?
Creatine Kinase
1
2014
73
0.030
 Why?
Socioeconomic Factors
1
2018
1212
0.030
 Why?
Epoxy Compounds
1
2014
32
0.030
 Why?
Nitrates
1
2014
87
0.030
 Why?
Quality Indicators, Health Care
1
2017
296
0.030
 Why?
Chondroitin Sulfates
1
2014
34
0.030
 Why?
Toll-Like Receptor 2
1
2014
112
0.030
 Why?
Kidney Function Tests
1
2014
145
0.030
 Why?
Manikins
1
2013
23
0.030
 Why?
Leukocyte Count
1
2014
326
0.030
 Why?
Liver Failure
1
2014
91
0.030
 Why?
Bronchial Spasm
1
2013
6
0.030
 Why?
Chromatography, Liquid
1
2015
381
0.030
 Why?
Cryptogenic Organizing Pneumonia
1
2013
17
0.030
 Why?
Quality Improvement
1
2021
1097
0.030
 Why?
Contraindications
1
2013
89
0.030
 Why?
Mass Spectrometry
1
2016
663
0.030
 Why?
Depression
1
2022
1292
0.030
 Why?
Anesthesiology
1
2013
45
0.030
 Why?
Tandem Mass Spectrometry
1
2015
456
0.030
 Why?
Glucuronidase
1
2012
43
0.020
 Why?
Protein C Deficiency
1
2012
8
0.020
 Why?
Connective Tissue Diseases
1
2013
80
0.020
 Why?
Cells, Cultured
1
2000
4017
0.020
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2012
83
0.020
 Why?
Knowledge Bases
1
2012
23
0.020
 Why?
Intestinal Perforation
1
2012
44
0.020
 Why?
Toll-Like Receptor 4
1
2014
263
0.020
 Why?
Triage
1
2014
205
0.020
 Why?
Renal Insufficiency
1
2014
148
0.020
 Why?
Quality of Health Care
1
2017
606
0.020
 Why?
Endothelium
1
2012
107
0.020
 Why?
Disease Management
1
2016
584
0.020
 Why?
Water-Electrolyte Balance
1
2011
32
0.020
 Why?
Quality Assurance, Health Care
1
2014
316
0.020
 Why?
Adoptive Transfer
1
2012
215
0.020
 Why?
Epistasis, Genetic
1
2012
70
0.020
 Why?
General Surgery
1
2013
152
0.020
 Why?
Cross-Over Studies
1
2013
509
0.020
 Why?
Cell Survival
1
2014
1076
0.020
 Why?
Microbial Viability
1
2011
83
0.020
 Why?
Superoxides
1
2011
198
0.020
 Why?
Internal Medicine
1
2013
246
0.020
 Why?
Enzyme Activation
1
2012
797
0.020
 Why?
Viruses
1
2011
100
0.020
 Why?
Interleukin-8
1
2011
262
0.020
 Why?
Cell Separation
1
2011
312
0.020
 Why?
Longitudinal Studies
1
2017
2710
0.020
 Why?
Single-Payer System
1
2009
2
0.020
 Why?
Species Specificity
1
2011
569
0.020
 Why?
Arthroplasty, Replacement, Knee
1
2014
301
0.020
 Why?
Disease-Free Survival
1
2011
647
0.020
 Why?
Administration, Inhalation
1
2011
661
0.020
 Why?
Cell Death
1
2011
343
0.020
 Why?
Survivors
1
2013
462
0.020
 Why?
Nitric Oxide
1
2014
881
0.020
 Why?
Information Dissemination
1
2011
204
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2011
820
0.020
 Why?
Advisory Committees
1
2010
214
0.020
 Why?
Case-Control Studies
1
2016
3339
0.020
 Why?
Self Report
1
2013
797
0.020
 Why?
Cell Line
1
2014
2741
0.020
 Why?
Drug Resistance, Bacterial
1
2009
176
0.020
 Why?
Total Quality Management
1
2008
60
0.020
 Why?
Ventilator Weaning
1
2008
37
0.020
 Why?
Precision Medicine
1
2012
386
0.020
 Why?
Microbial Sensitivity Tests
1
2009
352
0.020
 Why?
Placebos
1
2008
201
0.020
 Why?
Neutrophil Infiltration
1
2008
103
0.020
 Why?
Capillary Permeability
1
2008
131
0.020
 Why?
United States Food and Drug Administration
1
2008
198
0.020
 Why?
Health Plan Implementation
1
2008
137
0.020
 Why?
Interdisciplinary Communication
1
2008
185
0.020
 Why?
Drug Industry
1
2008
106
0.020
 Why?
Chemokines
1
2008
222
0.020
 Why?
Tumor Necrosis Factor-alpha
1
2012
1187
0.020
 Why?
Dose-Response Relationship, Drug
1
2011
1951
0.020
 Why?
Acid-Base Equilibrium
1
2007
27
0.020
 Why?
Cost Control
1
2006
39
0.020
 Why?
Umbilical Veins
1
2006
58
0.020
 Why?
Microcirculation
1
2007
137
0.020
 Why?
Medical Audit
1
2007
77
0.020
 Why?
Ketones
1
2007
47
0.020
 Why?
CD8 Antigens
1
2006
76
0.020
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2006
89
0.020
 Why?
CD4 Antigens
1
2006
138
0.020
 Why?
Bacillus subtilis
1
2006
65
0.020
 Why?
Information Management
1
2006
15
0.020
 Why?
Cell Count
1
2006
310
0.020
 Why?
Fluorescent Antibody Technique
1
2006
370
0.020
 Why?
Genome-Wide Association Study
1
2012
1332
0.010
 Why?
User-Computer Interface
1
2006
148
0.010
 Why?
Interleukin-10
1
2006
299
0.010
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2007
252
0.010
 Why?
Polymorphism, Single Nucleotide
1
2012
2064
0.010
 Why?
Inflammation Mediators
1
2006
498
0.010
 Why?
Asthma
1
2017
2213
0.010
 Why?
Hypoglycemia
1
2007
425
0.010
 Why?
Endothelium, Vascular
1
2007
844
0.010
 Why?
Cardiotonic Agents
1
2001
124
0.010
 Why?
Hypothermia, Induced
1
2001
73
0.010
 Why?
RNA, Messenger
1
2006
2679
0.010
 Why?
Mass Screening
1
2006
1146
0.010
 Why?
Dopamine
1
2001
285
0.010
 Why?
Hypoglycemic Agents
1
2007
1217
0.010
 Why?
Anti-Inflammatory Agents
1
2001
470
0.010
 Why?
Insulin
1
2007
2316
0.010
 Why?
Douglas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (598) concept(s)
_
Co-Authors Expand Description
See all (74) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)